ReviewPatient related outcome measures2018
Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis.
Charlotte Druart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it